PL353318A1 - Calcilytic compounds - Google Patents

Calcilytic compounds

Info

Publication number
PL353318A1
PL353318A1 PL00353318A PL35331800A PL353318A1 PL 353318 A1 PL353318 A1 PL 353318A1 PL 00353318 A PL00353318 A PL 00353318A PL 35331800 A PL35331800 A PL 35331800A PL 353318 A1 PL353318 A1 PL 353318A1
Authority
PL
Poland
Prior art keywords
calcilytic compounds
calcilytic
compounds
Prior art date
Application number
PL00353318A
Other languages
English (en)
Polish (pl)
Inventor
Maxine Gowen
Larry J. Suva
John Fox
George B. Stroup
Edward F. Nemeth
Original Assignee
Smithkline Beecham Corporation
Nps Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation, Nps Pharmaceuticals, Inc. filed Critical Smithkline Beecham Corporation
Publication of PL353318A1 publication Critical patent/PL353318A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
PL00353318A 1999-07-31 2000-07-31 Calcilytic compounds PL353318A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14677899P 1999-07-31 1999-07-31
PCT/US2000/020834 WO2001008673A1 (en) 1999-07-31 2000-07-31 Calcilytic compounds

Publications (1)

Publication Number Publication Date
PL353318A1 true PL353318A1 (en) 2003-11-17

Family

ID=22518969

Family Applications (1)

Application Number Title Priority Date Filing Date
PL00353318A PL353318A1 (en) 1999-07-31 2000-07-31 Calcilytic compounds

Country Status (21)

Country Link
EP (1) EP1200076A4 (tr)
JP (1) JP2003505502A (tr)
KR (1) KR20020016928A (tr)
CN (1) CN1367687A (tr)
AU (1) AU764716B2 (tr)
BR (1) BR0012921A (tr)
CA (1) CA2380081A1 (tr)
CO (1) CO5180628A1 (tr)
CZ (1) CZ2002360A3 (tr)
EC (1) ECSP003590A (tr)
HK (1) HK1046238A1 (tr)
HU (1) HUP0202167A3 (tr)
IL (1) IL147875A0 (tr)
MX (1) MXPA02001204A (tr)
NO (1) NO20020466L (tr)
PE (1) PE20010459A1 (tr)
PL (1) PL353318A1 (tr)
TR (1) TR200200278T2 (tr)
UY (1) UY26265A1 (tr)
WO (1) WO2001008673A1 (tr)
ZA (1) ZA200200784B (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030018203A1 (en) 2002-07-17 2003-01-23 Largo Maria Amparo Calcilytic compounds
AR030684A1 (es) * 2000-01-24 2003-09-03 Smithkline Beecham Corp Compuestos calciliticos, uso de dichos compuestos en la manufactura de medicamentos, e intermediarios utiles en la preparacion de dichos compuestos
US6756480B2 (en) 2000-04-27 2004-06-29 Amgen Inc. Modulators of receptors for parathyroid hormone and parathyroid hormone-related protein
TWI316511B (en) 2002-11-26 2009-11-01 Smithkline Beecham Corp Calcilytic compounds
US7205322B2 (en) 2003-02-12 2007-04-17 Bristol-Myers Squibb Company Thiazolidine compounds as calcium sensing receptor modulators
US7265145B2 (en) 2003-05-28 2007-09-04 Bristol-Myers Squibb Company Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
TW200845956A (en) * 2006-12-18 2008-12-01 Smithkline Beecham Corp Calcilytic compounds
WO2013098588A1 (en) * 2011-12-27 2013-07-04 Ubaldo Armato Use of calcilytic drugs as a pharmacological approach to the treatment and prevention of alzheimer's disease, alzheimer's disease-related disorders, and down's syndrome neuropathies
GB201217330D0 (en) 2012-09-28 2012-11-14 Univ Cardiff Therapeutic for treating inflammatory lung disorders
CN108420814A (zh) * 2017-02-15 2018-08-21 四川大学 一种nps-2143用于抗菌的新用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA002984B1 (ru) * 1996-04-09 2002-12-26 Эн Пи Эс Фармасьютикалз, Инк. Кальцилитические соединения, фармацевтические композиции и способ скрининга кальцилитических соединений
MY121054A (en) * 1998-04-08 2005-12-30 Smithkline Beecham Corp Calcilytic compounds as calcium receptor antagonists.
AR014975A1 (es) * 1998-04-08 2001-04-11 Nps Pharma Inc Compuestos calciliticos, una composicion farmaceutica que los comprende, y el uso de los mismos para la fabricacion de un medicamento

Also Published As

Publication number Publication date
EP1200076A1 (en) 2002-05-02
BR0012921A (pt) 2002-06-18
NO20020466L (no) 2002-03-20
WO2001008673A1 (en) 2001-02-08
KR20020016928A (ko) 2002-03-06
ZA200200784B (en) 2003-01-29
CO5180628A1 (es) 2002-07-30
AU764716B2 (en) 2003-08-28
MXPA02001204A (es) 2004-05-21
AU6504100A (en) 2001-02-19
PE20010459A1 (es) 2001-06-11
HK1046238A1 (zh) 2003-01-03
ECSP003590A (es) 2002-02-25
EP1200076A4 (en) 2005-02-09
CA2380081A1 (en) 2001-02-08
TR200200278T2 (tr) 2002-06-21
IL147875A0 (en) 2002-08-14
NO20020466D0 (no) 2002-01-29
CN1367687A (zh) 2002-09-04
UY26265A1 (es) 2001-03-16
HUP0202167A3 (en) 2006-07-28
JP2003505502A (ja) 2003-02-12
HUP0202167A2 (en) 2002-10-28
CZ2002360A3 (cs) 2002-10-16

Similar Documents

Publication Publication Date Title
PL352911A1 (en) New compounds
GB2357761B (en) Compounds
PL354360A1 (en) New compounds
EG24178A (en) Calcilytic compounds
EP1104411A4 (en) CALCILYTIC COMPOUNDS
IL144470A0 (en) Calcilytic compounds
HUP0202167A2 (en) Calcilytic compounds
HK1042493A1 (zh) 新的化合物
IL150398A0 (en) Calcilytic compounds
IL155522A0 (en) Calcilytic compounds
AU7692301A (en) Calcilytic compounds
EP1112073A4 (en) CALCILYTIC COMPOUNDS
GB9902399D0 (en) Compounds
HUP9904624D0 (en) New compounds
SI1202994T1 (en) New compounds
GB9903280D0 (en) Compounds
GB9903243D0 (en) Compounds
GB9903271D0 (en) Compounds
GB9907456D0 (en) Compounds
GB9903269D0 (en) Compounds
GB9903268D0 (en) Compounds
GB9903266D0 (en) Compounds
GB9903272D0 (en) Compounds
GB9903241D0 (en) Compounds
GB9901423D0 (en) Compounds

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)